Works matching IS 1175-3277 AND VI 23 AND IP 1 AND DT 2023


Results: 10
    1
    2
    3
    4
    5
    6

    Antithrombotic Strategy in Secondary Prevention for High-Risk Patients with Previous Acute Coronary Syndrome: Overlap between the PEGASUS Eligibility and the COMPASS Eligibility in a Large Multicenter Registry.

    Published in:
    American Journal of Cardiovascular Drugs, 2023, v. 23, n. 1, p. 77, doi. 10.1007/s40256-022-00554-5
    By:
    • Millesimo, Michele;
    • Elia, Edoardo;
    • Marengo, Giorgio;
    • De Filippo, Ovidio;
    • Raposeiras-Roubin, Sergio;
    • Wańha, Wojciech;
    • Abu-Assi, Emad;
    • Kinnaird, Tim;
    • Ariza-Solé, Albert;
    • Liebetrau, Christoph;
    • Manzano-Fernández, Sergio;
    • Iannaccone, Mario;
    • Henriques, Jose Paulo Simao;
    • Templin, Christian;
    • Wilton, Stephen B.;
    • Velicki, Lazar;
    • Xanthopoulou, Ioanna;
    • Correia, Luis;
    • Cerrato, Enrico;
    • Rognoni, Andrea
    Publication type:
    Article
    7
    8

    Potential Cardiovascular Events Avoided with Bempedoic Acid Plus Ezetimibe Fixed-Dose Combination Compared with Ezetimibe Alone in Patients with Atherosclerotic Cardiovascular Disease Taking Maximally Tolerated Statins.

    Published in:
    American Journal of Cardiovascular Drugs, 2023, v. 23, n. 1, p. 67, doi. 10.1007/s40256-022-00552-7
    By:
    • McQueen, R. Brett;
    • Baum, Seth J.;
    • Louie, Michael J.;
    • Sasiela, William J.;
    • Bilitou, Aikaterini;
    • Shah, Hemal;
    • Nash, Beth;
    • Gillard, Kristin K.;
    • Ray, Kausik K.
    Publication type:
    Article
    9
    10